arrow
返回
T

Takeshi Hatanaka

Gunma Saiseikai Maebashi Hospital

25H指数
218论文数
2.6K被引数
收录论文 74
发表时间
Prognostic Value of the FIB-3 Index in Patients With Hepatic Encephalopathy Receiving Rifaximin: A Multicenter Retrospective AnalysisFIB-3指数在服用利福昔明的肝性脑病患者中的预后价值:一项多中心回顾性分析
err2026-09-15
err0
PREAI
errTakeshi Hatanaka; Satoru Kakizaki; Rintaro Kobayashi; Yuki Kanayama; Satoshi Takakusagi; Takashi Kosone; Atsushi Naganuma; Hiroki Tojima; Yuichi Yamazaki; Hitoshi Takagi; Toshio Uraoka
err分享
err收藏
Real-world efficacy and safety of avatrombopag in Japanese patients with chronic liver disease and severe thrombocytopenia阿伐曲泊帕在日本慢性肝病合并重度血小板减少症患者中的真实世界有效性与安全性
err2026-07-30
err0
PREAI
errYosuke Otsuka; Naoki Morimoto; Satoru Kakizaki; Tadashi Ikegami; Shunji Watanabe; Yuichi Majima; Hirotaka Arai; Takeharu Asano; Yoshihito Uchida; Toshiro Kamoshida; Takeshi Hatanaka; Satoshi Takakusagi; Takeshi Nihei; Atsuko Soeda; Yuichi Yamazaki; Naoyuki Hasegawa; Hidekazu Kurata; Takayoshi Suga; Toshiyuki Tahara; Rie Goka; Mamiko Tsukui; Wataru Ueno; Kouichi Miura; Tomonori Yano; Satoshi Mochida
err分享
err收藏
Compensatory Hepatic Hypertrophy After Carbon Ion Radiotherapy for Hepatocellular Carcinoma: Factors Associated With Its Development and Relationship With Prognosis碳离子放射治疗肝癌后的代偿性肝肥大:其发生相关因素及与预后的关系
err2026-05-22
err0
PREAI
errTatsuma Murakami; Takeshi Hatanaka; Yumeo Tateyama; Hiroki Tojima; Yuichi Yamazaki; Yuhei Miyasaka; Kei Shibuya; Atsushi Naganuma; Satoru Kakizaki; Tatsuya Ohno; Toshio Uraoka
err分享
err收藏
Ablation-Based Salvage Strategy at Disease Progression After Initial Disease Control With Atezolizumab/Bevacizumab in Hepatocellular Carcinoma在初始使用阿替利珠单抗/贝伐珠单抗控制疾病后,疾病进展时基于消融的挽救策略在肝细胞癌中的应用
err2026-05-11
err0
PREAI
errKazuya Kariyama; Kazuhiro Nouso; Atsushi Hiraoka; Fujimasa Tada; Hideko Ohama; Hidenori Toyoda; Satoshi Yasuda; Toshifumi Tada; Kazunari Tanaka; Kunihiko Tsuji; Ei Itobayashi; Akemi Tsutsui; Koichi Takaguchi; Michitaka Imai; Toru Ishikawa; Takeshi Hatanaka; Yuki Kanayama; Satoru Kakizaki; Atsushi Naganuma; Yoshihide Ueda; Tomomitsu Matono; Hideyuki Tamai; Junpei Okamura; Hironori Tanaka; Yutaka Yata; Akiko Wakuta; Masatoshi Kudo; Takashi Kumada
err分享
err收藏
Efficacy and Safety of Stereotactic Body Radiation Therapy in Patients With Hepatocellular Carcinoma in the Caudate Lobe: A Comparative Study With Radiofrequency Ablation尾状叶肝细胞癌患者立体定向体部放射治疗的疗效与安全性:与射频消融的对比研究
err2026-04-28
err0
PREAI
errYuki Tamura; Hirotaka Arai; Hiroki Kiyohara; Yukihiko Yoshimatsu; Satoru Kakizaki; Yuki Kanayama; Takeshi Hatanaka; Atsushi Naganuma; Takashi Ueno; Satoshi Takakusagi; Toru Fukuchi; Hiroki Tojima; Yuichi Yamazaki; Kei Shibuya; Tatsuya Ohno; Toshio Uraoka
err分享
err收藏
Clinical Characteristics, Predictive Factors, and the Impact of Antithrombotic Therapy on Bleeding Events in Unresectable Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab不可切除性肝细胞癌接受阿替利珠单抗联合贝伐珠单抗治疗后出血事件的临床特征、预测因素及抗血栓治疗的影响
err2026-04-21
err0
PREAI
errFujimasa Tada; Atsushi Hiraoka; Hideko Ohama; Toshifumi Tada; Masashi Hirooka; Kazuya Kariyama; Joji Tani; Masanori Atsukawa; Koichi Takaguchi; Ei Itobayashi; Shinya Fukunishi; Kunihiko Tsuji; Toru Ishikawa; Kazuto Tajiri; Hironori Tanaka; Hidenori Toyoda; Chikara Ogawa; Takashi Nishimura; Takeshi Hatanaka; Satoru Kakizaki; Kazuhito Kawata; Atsushi Naganuma; Hisashi Kosaka; Tomomitsu Matono; Yoshihide Ueda; Hidekatsu Kuroda; Yutaka Yata; Hiroki Nishikawa; Michitaka Imai; Tomoko Aoki; Hironori Ochi; Jumpei Okamura; Hideyuki Tamai; Shinichiro Nakamura; Yoshiko Nakamura; Osamu Yoshida; Kazuhiro Nouso; Asahiro Morishita; Norio Itokawa; Tomomi Okubo; Taeang Arai; Akemi Tsutsui; Takuya Nagano; Kazunari Tanaka; Yuichi Koshiyama; Yuki Kanayama; Hidenao Noritake; Shohei Komatsu; Takumi Fukumoto; Takanori Matsuura; Soo Ki Kim; Hirayuki Enomoto; Kosuke Matsui; Masaki Kaibori; Yoichi Hiasa; Masatoshi Kudo; Takashi Kumada; the Real-life Practice Experts for HCC (RELPEC) Study Group and hepatocellular carcinoma experts from 48 clinics in Japan (HCC 48) Group
err分享
err收藏
Impact of Intrahepatic Tumor Burden on Outcomes in Patients With Hepatocellular Carcinoma With Extrahepatic Metastases Treated With Atezolizumab Plus Bevacizumab肝内肿瘤负荷对接受阿替利珠单抗联合贝伐珠单抗治疗的合并肝外转移的肝细胞癌患者预后的影响
err2026-04-10
err0
PREAI
errKazunari Tanaka; Kunihiko Tsuji; Atsushi Hiraoka; Toshifumi Tada; Masashi Hirooka; Kazuya Kariyama; Joji Tani; Masanori Atsukawa; Koichi Takaguchi; Ei Itobayashi; Shinya Fukunishi; Toru Ishikawa; Kazuto Tajiri; Hironori Tanaka; Hidenori Toyoda; Chikara Ogawa; Takashi Nishimura; Takeshi Hatanaka; Satoru Kakizaki; Kazuhito Kawata; Atsushi Naganuma; Hisashi Kosaka; Tomomitsu Matono; Yoshihide Ueda; Hidekatsu Kuroda; Yutaka Yata; Hiroki Nishikawa; Michitaka Imai; Tomoko Aoki; Hironori Ochi; Jumpei Okamura; Hideyuki Tamai; Shinichiro Nakamura; Yoshiko Nakamura; Osamu Yoshida; Kazuhiro Nouso; Asahiro Morishita; Norio Itokawa; Tomomi Okubo; Taeang Arai; Akemi Tsutsui; Takuya Nagano; Fujimasa Tada; Hideko Ohama; Yuichi Koshiyama; Yuki Kanayama; Hidenao Noritake; Shohei Komatsu; Takumi Fukumoto; Takanori Matsuura; Soo Ki Kim; Hirayuki Enomoto; Kosuke Matsui; Masaki Kaibori; Yoichi Hiasa; Masatoshi Kudo; Takashi Kumada; the Real-Life Practice Experts for HCC (RELPEC) Study Group and Hepatocellular Carcinoma Experts From 48 Clinics in Japan (HCC 48) Group
err分享
err收藏
Long-Term Outcomes of Sofosbuvir/Velpatasvir Treatment for Hepatitis C Virus-Related Decompensated Cirrhosis: A Retrospective Multicenter Cohort Study索磷布韦/维帕他韦治疗丙型肝炎病毒相关失代偿期肝硬化的长期疗效:一项回顾性多中心队列研究
err2026-04-01
err0
PREAI
errSatoru Kakizaki; Tadashi Ikegami; Takeshi Hatanaka; Yuhei Suzuki; Takashi Hoshino; Atsushi Naganuma; Daichi Takizawa; Hirotaka Arai; Takashi Ueno; Keisuke Iizuka; Takahiro Arisaka; Yuichi Majima; Makoto Iijima; Shigeo Tano; Toshiyuki Tahara; Masahiro Araki; Toshiro Kamoshida; Yoshinari Takaoka; Hidekazu Kurata; Yukimura Fukaya; Kuniaki Fukuda; Atsuko Soeda; Takayoshi Suga; Shuichi Saito; Toru Fukuchi; Satoshi Takakusagi; Hitoshi Takagi; Katsuhiko Horiuchi; Yuki Kanayama; Toshiya Ohtake; Hiroki Tojima; Yuichi Yamazaki; Shunji Watanabe; Kouichi Miura; Naoki Morimoto; Liver Investigators in the Northern Kanto Study (LINKS) group
err分享
err收藏
Lymphocyte–Monocyte Ratio Predicts the Survival in Patients With HCC Treated With Durvalumab Plus Tremelimumab淋巴细胞-单核细胞比值预测接受度鲁单单抗联合曲美单抗治疗的HCC患者的生存情况
err2026-02-26
err0
PREAI
errTomomitsu Matono; Toshifumi Tada; Atsushi Hiraoka; Masashi Hirooka; Kazuya Kariyama; Joji Tani; Masanori Atsukawa; Koichi Takaguchi; Ei Itobayashi; Takashi Nishimura; Kunihiko Tsuji; Toru Ishikawa; Kazuto Tajiri; Hironori Tanaka; Hidenori Toyoda; Chikara Ogawa; Takeshi Hatanaka; Satoru Kakizaki; Kazuhito Kawata; Atsushi Naganuma; Hisashi Kosaka; Hidekatsu Kuroda; Yutaka Yata; Hiroki Nishikawa; Michitaka Imai; Tomoko Aoki; Hironori Ochi; Hideyuki Tamai; Shohei Komatsu; Takanori Matsuura; Yoshihide Ueda; Soo Ki Kim; Hideko Ohama; Fujimasa Tada; Shinichiro Nakamura; Yoshiko Nakamura; Osamu Yoshida; Kazuhiro Nouso; Asahiro Morishita; Norio Itokawa; Tomomi Okubo; Taeang Arai; Akemi Tsutsui; Takuya Nagano; Shinya Fukunishi; Kazunari Tanaka; Yuichi Koshiyama; Yuki Kanayama; Hidenao Noritake; Hirayuki Enomoto; Kosuke Matsui; Masaki Kaibori; Jumpei Okamura; Takumi Fukumoto; Yoichi Hiasa; Masatoshi Kudo; Takashi Kumada; the RELPEC Group and HCC 48 Group
err分享
err收藏
Efficacy and Safety of Durvalumab Plus Tremelimumab in Hepatocellular Carcinoma Patients With Portal Vein Thrombosis and High Tumor Burden: A Multicenter Retrospective Analysis度鲁特玛联合特瑞普利单抗在合并门静脉血栓和高肿瘤负荷的肝细胞癌患者中的有效性与安全性:一项多中心回顾性分析
err2025-09-06
err0
PREAI
errHatanaka, Takeshi; Yata, Yutaka; Hiraoka, Atsushi; Tada, Toshifumi; Hirooka, Masashi; Kariyama, Kazuya; Tani, Joji; Atsukawa, Masanori; Takaguchi, Koichi; Itobayashi, Ei; Kakizaki, Satoru; Fukunishi, Shinya; Tsuji, Kunihiko; Ishikawa, Toru; Tajiri, Kazuto; Toyoda, Hidenori; Koshiyama, Yuichi; Ogawa, Chikara; Nishikawa, Hiroki; Nishimura, Takashi; Kawata, Kazuhito; Kosaka, Hisashi; Matsui, Kosuke; Naganuma, Atsushi; Tanaka, Hironori; Ohama, Hideko; Kuroda, Hidekatsu; Matono, Tomomitsu; Aoki, Tomoko; Ochi, Hironori; Imai, Michitaka; Nakamura, Shinichiro; Komatsu, Shohei; Tamai, Hideyuki; Okamura, Jumpei; Kanayama, Yuki; Tanaka, Kazunari; Tada, Fujimasa; Yoshida, Osamu; Nouso, Kazuhiro; Morishita, Asahiro; Tsutsui, Akemi; Nagano, Takuya; Itokawa, Norio; Okubo, Tomomi; Arai, Taeang; Matsuura, Takanori; Noritake, Hidenao; Enomoto, Hirayuki; Kaibori, Masaki; Fukumoto, Takumi; Hiasa, Yoichi; Kudo, Masatoshi; Kumada, Takashi
err分享
err收藏
Carbon-ion radiotherapy achieves outcomes equivalent to surgical resection for hepatocellular carcinoma碳离子放射治疗对于肝细胞癌的治疗效果与手术切除相当。
err2025-08-29
err0
errOAAI
errHatanaka, Takeshi; Shibuya, Kei; Kakizaki, Satoru; Hiraoka, Atsushi; Tada, Toshifumi; Kariyama, Kazuya; Itobayashi, Ei; Tsuji, Kunihiko; Ishikawa, Toru; Toyoda, Hidenori; Koshiyama, Yuichi; Naganuma, Atsushi; Miyasaka, Yuhei; Kanayama, Yuki; Tanaka, Kazunari; Tada, Fujimasa; Ohama, Hideko; Nouso, Kazuhiro; Nakamura, Shinichiro; Kumada, Takashi; Ohno, Tatsuya; On behalf of the Real-life Practice Experts for HCC (RELPEC) Study Group
err分享
err收藏
Association of Metabolic-Associated Steatotic Liver Disease With Clinical Outcomes of Durvalumab and Tremelimumab in Advanced Hepatocellular Carcinoma Patients: A Multicenter Study代谢相关脂肪性肝病与度伐利尤单抗和特瑞普利单抗在晚期肝细胞癌患者临床结局中的关联:一项多中心研究
err2025-08-21
err0
PREAI
errTakeshi Hatanaka; Shigeo Shimose; Takanori Ito; Joji Tani; Tetsu Tomonari; Issei Saeki; Yasuto Takeuchi; Kyo Sasaki; Yuichi Honma; Ryu Sasaki; Naoki Yoshioka; Takehito Naito; Mamiko Takeuchi; Tetsuya Yasunaka; Masahiro Sakata; Hideki Iwamoto; Satoshi Itano; Yuki Kanayama; Tomotake Shirono; Norikazu Tanabe; Takafumi Yamamoto; Atsushi Naganuma; Sohji Nishina; Motoyuki Otsuka; Hideki Kobara; Taro Takami; Tetsuji Takayama; Takumi Kawaguchi; Hiroki Kawashima; Masaru Harada; Hisamitsu Miyaaki; Satoru Kakizaki; Hepatology InVestigator Experts in Japan (HIVE-J) Study Group
err分享
err收藏
Potential role of Geriatric Nutritional Risk Index as a risk factor for immune-mediated adverse events during durvalumab plus tremelimumab therapy in unresectable hepatocellular carcinoma格瑞特营养风险指数作为不可切除肝癌患者接受度伐利尤单抗联合特瑞普利单抗治疗期间免疫介导不良反应的风险因素的潜在作用
err2025-08-20
err0
PREAI
errHideko Ohama; Atsushi Hiraoka; Toshifumi Tada; Masashi Hirooka; Kazuya Kariyama; Joji Tani; Masanori Atsukawa; Koichi Takaguchi; Ei Itobayashi; Shinya Fukunishi; Kunihiko Tsuji; Toru Ishikawa; Kazuto Tajiri; Hironori Tanaka; Hidenori Toyoda; Chikara Ogawa; Takashi Nishimura; Takeshi Hatanaka; Satoru Kakizaki; Kazuhito Kawata; Atsushi Naganuma; Hisashi Kosaka; Tomomitsu Matono; Hidekatsu Kuroda; Yutaka Yata; Hiroki Nishikawa; Michitaka Imai; Tomoko Aoki; Hironori Ochi; Hideyuki Tamai; Shohei Komatsu; Fujimasa Tada; Shinichiro Nakamura; Yoshiko Nakamura; Teruki Miyake; Osamu Yoshida; Kazuhiro Nouso; Asahiro Morishita; Norio Itokawa; Tomomi Okubo; Taeang Arai; Akemi Tsutsui; Takuya Nagano; Kazunari Tanaka; Takanori Matsuura; Yuichi Koshiyama; Yuki Kanayama; Hidenao Noritake; Hirayuki Enomoto; Kosuke Matsui; Masaki Kaibori; Takumi Fukumoto; Yoichi Hiasa; Masatoshi Kudo; Takashi Kumada
err分享
err收藏
Safety and Efficacy of Durvalumab Plus Tremelimumab in Older Individuals With Unresectable Hepatocellular Carcinoma: A Multicenter Analysis达鲁瓦鲁单抗联合特雷美鲁单抗在不可切除肝细胞癌老年患者中的安全性与有效性:一项多中心分析
err2025-08-06
err0
PREAI
errTomomitsu Matono; Toshifumi Tada; Takashi Kumada; Atsushi Hiraoka; Masashi Hirooka; Kazuya Kariyama; Joji Tani; Masanori Atsukawa; Koichi Takaguchi; Ei Itobayashi; Shinya Fukunishi; Hiroki Nishikawa; Kazunari Tanaka; Kunihiko Tsuji; Toru Ishikawa; Kazuto Tajiri; Yuichi Koshiyama; Hidenori Toyoda; Chikara Ogawa; Takeshi Hatanaka; Satoru Kakizaki; Kazuhito Kawata; Hidenao Noritake; Hideko Ohama; Fujimasa Tada; Kazuhiro Nouso; Asahiro Morishita; Akemi Tsutsui; Takuya Nagano; Norio Itokawa; Tomomi Okubo; Taeang Arai; Takashi Nishimura; Michitaka Imai; Hisashi Kosaka; Atsushi Naganuma; Tomoko Aoki; Hidekatsu Kuroda; Yutaka Yata; Hideyuki Tamai; Takanori Matsuura; Shohei Komatsu; Yoshihide Ueda; Yoshiko Nakamura; Osamu Yoshida; Kosuke Matsui; Shinichiro Nakamura; Hirayuki Enomoto; Masaki Kaibori; Takumi Fukumoto; Yoichi Hiasa; Masatoshi Kudo; the Real-life Practice Experts for HCC (RELPEC) Study Group and the Hepatocellular Carcinoma Experts From 48 Clinics in Japan (HCC 48) Group
err分享
err收藏
Comparison of Surgical Resection and Radiofrequency Ablation for Early-Stage HCC Patients With Child-Pugh Class B早期肝细胞癌Child-Pugh B级患者手术切除与射频消融的比较
err2025-05-27
err0
PREAI
errTakeshi Hatanaka; Satoru Kakizaki; Atsushi Hiraoka; Toshifumi Tada; Kazuya Kariyama; Ei Itobayashi; Kunihiko Tsuji; Toru Ishikawa; Hidenori Toyoda
err分享
err收藏
The benefit of conversion therapy for patients with unresectable hepatocellular carcinoma receiving atezolizumab plus bevacizumab using newly established oncological resectability criteria in Japan
err2025-02-28
err0
PREAI
errShimose, Shigeo; Saeki, Issei; Ito, Takanori; Takeuchi, Yasuto; Tani, Joji; Tomonari, Tetsu; Sasaki, Ryu; Sasaki, Kyo; Kakizaki, Satoru; Hatanaka, Takeshi; Iwamoto, Hideki; Tanabe, Norikazu; Yamamoto, Takafumi; Naganuma, Atsushi; Shirono, Tomotake; Kanayama, Yuki; Nishina, Sohji; Takayama, Tetsuji; Kobara, Hideki; Otsuka, Motoyuki; Kawashima, Hiroki; Takami, Taro; Kawaguchi, Takumi; Hepatology InVestigator Experts Japan HIVE-J Study Grp
err分享
err收藏